€121,- €100,- hors TVA
Canine Degenerative Myelopathy (DM) is an incurable progressive neurodegenerative disease of the spinal cord.
25 working days
Excl €5,95 shipping and administration per order (incl. VAT)
Caractéristiques
| Breeds | American Water Spaniel, Berger allemand, Berger australien, Borzoi, Bouvier Bernois, Caniche standard, Cardigan Gallois Corgi, carlin, Chien de berger des Shetland, Chien de Rhodésie à crête dorsale (Rhodesian Ridgeback), Chien de Saint-Hubert, Deerhound écossais, Épagneul Springer anglais, Esquimau américain, Husky de Sibérie, Retriever de la baie de Chesapeake, Retriever de la Nouvelle-Écosse, Terrier de wheaten à pelage tendre, Terrier irlandais Glen of Imaal, Terrier Kerry Blue, Wire Fox Terrier, Airedale Terrier, Komondor, Boxer, Boykin Spaniel, Cavalier King Charles Spaniel, Golden Retriever, Jack Russell Terrier, Labrador Retriever, Welsh Corgi Pembroke |
|---|---|
| Gene | |
| Organ | |
| specimen | Swab, Blood EDTA, Blood Heparin, Semen, Tissue |
| Mode of Inheritance | |
| Chromosome | |
| Also known as | |
| Year Published |
Informations générales
Canine Degenerative Myelopathy (DM) is an incurable progressive neurodegenerative disease of the spinal cord. Neurodegenerative diseases are characterised by progressive loss of neurons in the central nervous system (CNS) which leads to deficiencies in function. In the case of DM, the affected region is the spinal cord, which results in ataxia (a loss of coordination). DM is similar in many ways to Amyotrophic Lateral Sclerosis (ALS) in humans.
This variant of the disease, sometimes designated as SOD1B or as Degenerative Myelopathy Exon 2, occurs in many different breeds. It is probely caused by a autosomal recessive with incomplete penetrance mutation to the gene SOD1. The variant is found in many breeds, but the disease is rarely diagnosed in breeds or in mixed-breed dogs other than those mentioned for this test.
Caractéristiques cliniques
The mutation for DM is present in almost all dog breeds, but in many breeds, it does not cause clinical symptoms. Most dogs that might be affected are at least 5 years of age or older, at the onset of the clinical signs which include reduced strength in the hind legs, incontinence, hyporeflexia, spasticity and ataxia of the pelvic with progression over time to complete paralysis.
Additional Information
This test is performed by an external laboratory. CombiBreed takes care of the mediation between you as a customer and the external laboratory. In this case, CombiBreed cannot be held liable for the behaviour of the client and/or contractor.
Références
Pubmed ID: 19188595
Omia ID: 263